Cañete, Edame .

HRN: 21-84-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2022
CEFUROXIME 750MG (VIAL)
08/29/2022
08/31/2022
IVT
750mg
Q8
VBAC With RMLE And Repiar

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines